Categories: HealthcareNews

Glenview Capital Issues Statement on CVS Health

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NEW YORK, Oct. 1, 2024 /PRNewswire/ — We appreciate the skill and dedication of everyone at CVS Health and their daily efforts to make healthcare accessible, affordable and convenient for more than 120 million members and customers.  CVS Health is a systemically important healthcare institution whose consistency, quality and acumen has the potential to enhance wellness and health security for one in three Americans.  While the Company has tremendous assets across medical and pharmacy benefit management, specialty pharmacy, provider services and drug retail, the Company is operating well below its potential and has fallen short in its investment and actuarial approach in recent years, creating economic losses and volatility that pressures its people, its customers and its shareholders. 

Glenview and CVS Leadership are engaged in good faith and constructive conversations through which Glenview is offering suggestions to enhance the governance, culture, efficiency, sustainability and growth of CVS Health.  This dialogue is ongoing but is private and should remain so.  Press reports have represented that Glenview is pushing for a break-up of CVS Health – this is false.  Our goals are those shared by all stakeholders – to work together to strengthen CVS’s culture and operating performance to enhance value for customers, associates and shareholders alike. 

Together we build.

About Glenview Capital
In its 24th year of operations, Glenview Capital is a long-term investment partnership focused on fundamental investing.

CONTACT: Emma Tomas, etomas@hstrategies.com

View original content:https://www.prnewswire.com/news-releases/glenview-capital-issues-statement-on-cvs-health-302264708.html

SOURCE Glenview Capital

Staff

Recent Posts

Endogenex Highlights 48-Week REGENT-1 Clinical Study Results at Digestive Disease Week 2025

Novel Endoscopic Procedure Demonstrates Substantial and Durable Reduction in Insulin Resistance and Improvement in Beta…

30 minutes ago

SlimJaro Canada, Australia, UK, Reviews, Official Website, Discount Code, Trustpilot Complaints

Slimjaro Slimjaro Lakeland, FL, May 03, 2025 (GLOBE NEWSWIRE) -- SlimJaro Canada: The Revolutionary Fat-Burning…

34 minutes ago

Javy Protein Coffee Under Review: Best Protein Coffee with Premium Ingredients by Javy Protein Coffee

Discover why Javy Protein Coffee is the best protein coffee for energy, recovery, and flavor.…

35 minutes ago

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader…

35 minutes ago

INP and Fight For Life Club Foundation Make History: Two Pediatric Living Donor Liver Transplants in One Week

Dallas, Texas, May 02, 2025 (GLOBE NEWSWIRE) -- In a historic medical achievement, the National…

35 minutes ago

RaySearch Laboratories and Vision RT present innovations in surface guided treatment planning at ESTRO

STOCKHOLM, May 3, 2025 /PRNewswire/ -- At this week's ESTRO conference in Vienna, RaySearch Laboratories…

4 hours ago